Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear

Journal of the American Academy of Dermatology

Volumn 49, Issue 2, 2003, Pages 213-216

  Heckmann, Marc ^a,b,c   Teichmann, Bianca ^a,b   Schröder, Ulrike ^d   Sprengelmeyer, Reiner ^e   Ceballos Baumann, Andrés O ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Skin Center Starnberg   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ANGER; ARTICLE; CLINICAL ARTICLE; EMOTION; FACE MUSCLE; FACIAL EXPRESSION; FEAR; HAPPINESS; HUMAN; HUMAN EXPERIMENT; MUSCLE CONTRACTION; MUSCLE DENERVATION; NORMAL HUMAN; PHOTOGRAPHY; PRIORITY JOURNAL;

EID: 0043135055     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00909-5     Document Type: Article

References (27)

1. Ekman P, Rosenberg EL. What the face reveals: basic and applied studies of spontaneous expression using the facial action coding system (FACS). New York: Oxford University Press; 1998.
2. Darwin C. The expression of the emotions in man and animals. 3rd ed. London: Oxford University Press; 1998.
3. Ekman P, Friesen WV. Pictures of facial affect. Palo Alto (CA): Consulting Psychologists Press; 1975.
4. Jancke L. Facial EMG in an anger-provoking situation: individual differences in directing anger outwards or inwards. Int J Psychophysiol 1996;23:207-14.
5. Dimberg U. Facial reactions to fear-relevant and fear-irrelevant stimuli. Biol Psychol 1986;23:153-61.
6. Brown SL, Schwartz GE. Relationships between facial electromyography and subjective experience during affective imagery. Biol Psychol 1980;11:49-62.
7. Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 1992;239:16-20.
8. Munchau A, Bhatia KP. Uses of botulinum toxin injection in medicine today. BMJ 2000;320:161-5.
9. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.
10. Ceballos-Baumann AO. Evidence-based medicine in botulinum toxin therapy for cervical dystonia. J Neurol 2001;248:14-20.
11. Annese V, Bassotti G, Coccia G, Dinelli M, D'Onofrio V, Gatto G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gut 2000;46:597-600.
12. Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65-9.
13. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488-93.
14. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001;323:596.
15. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C botulinum-A exotoxin. J Dermatol Surg Oncol 1992;18:17-21.
16. Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1189-94.
17. Lowe NJ, Maxwell A, Harper H. Botulinum-A exotoxin for glabellar folds: a double blind, placebo controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:569-72.
18. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993;119:1018-22.
19. Calder AJ, Rowland D, Young AW, Nimmo-Smith I, Keane J, Perrett DI. Caricaturing facial expressions. Cognition 2000;76:105-46.
20. Carney RM, Hong BA, O'Connell MF, Amado H. Facial electromyography as a predictor of treatment outcome in depression. Br J Psychiatry 1981;138:485-9.
21. Greden JF, Genero N, Price HL. Agitation-increased electromyogram activity in the corrugator muscle region: a possible explanation of the "omega sign"? Am J Psychiatry 1985;142:348-51.
22. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001;41:658-64.
23. Merzenich M. Long-term change of mind. Science 1998;282:1062-3.
24. Ceballos-Baumann AO, Sheean G, Passingham RE, Marsden CD, Brooks DJ. Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp: a PET study. Brain 1997;120:571-82.
25. Adolphs R, Damasio H, Tranel D, Cooper G, Damasio AR. A role for somatosensory cortices in the visual recognition of emotion as revealed by three-dimensional lesion mapping. J Neurosci 2000;20:2683-90.
26. Adelmann PK, Zajonc RB. Facial efference and the experience of emotion. Annu Rev Psychol 1989;40:249-80.
27. Damasio AR. The feeling of what happens: body and emotion in the making of consciousness. New York: Harcourt Brace; 1999.